Regulus Therapeutics Inc.·4

May 21, 4:23 PM ET

Witz Pascale 4

4 · Regulus Therapeutics Inc. · Filed May 21, 2024

Insider Transaction Report

Form 4
Period: 2024-05-20
Witz Pascale
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-20+60,00060,000 total
    Exercise: $2.01Exp: 2034-05-19Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The options will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual shareholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4